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Abstract
Background—The objective of this study was to determine the feasibility of postpartum LNG-
IUS placement on the postpartum ward.
Study Design—This case-series study took place in a teaching hospital in North Carolina.
Women were followed for six months and data on method satisfaction, study design satisfaction
and expulsion were collected. Descriptive statistics were used.
Results—Forty women enrolled. Twenty-nine women (73%) received the LNG-IUS at a median
of 20 h (range 7– 48h) after delivery, and all reported they would recommend this method of
contraception to a friend. Eleven women had a spontaneous expulsion [38% (95% confidence
interval 21, 58)].
Conclusion—Placement of LNG-IUS more than 6 h postpartum was acceptable to women in
this study. The expulsion rate of 38% had statistical instability and should be interpreted with
caution. However, our report may assist with individual counseling of women interested in
postpartum LNG-IUS placement, or in future study designs.
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1. Introduction
Unintended pregnancy occurs in up to 50% of all pregnancies in the United States [1]. The
immediate postpartum period, after a birth but prior to discharge from the hospital, is an
important, but underutilized time frame to initiate contraceptives, especially long acting
contraceptives such as the subdermal implant or the intrauterine device (IUD) [2,3]. Women
are often motivated to prevent or delay another pregnancy, they have immediate access to
health care providers, they are known not be pregnant, and they may have uterine anesthesia
in place. Postpartum intrauterine device (IUD) placement in particular may increase
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utilization of postpartum contraception because up to 45% of women who state a desire to
use the IUD postpartum may never receive one due to failure to return for the postpartum
visit, early repeat pregnancy, or financial barriers [3,4].
Although postpartum placement of the Copper T380A IUD (CuT380A) within 48 h of birth
is condoned in national and international family planning practice guidelines, there are
limited data on placement of the levonorgestrel intrauterine system (LNG-IUS) more than a
few hours after birth [5,6]. Recent data from the United States indicate that postplacental
(within 10 min of placental delivery) LNG-IUS placement is acceptable to women, but is
also associated with spontaneous expulsions occurring in 10–28% of women at 6 months
[7,8]. Dahlke et al. [8] reported their experience of placing the LNG-IUS 30 min
postplacentally in the delivery room, and they reported an expulsion rate of 24%. An
important limiting factor to increased uptake of immediate postpartum IUD insertion are
older, but highly variable, data reporting expulsion rates of the CuT380A from as low as 5%
to as high as 70% [9, 10, 11]. Limited data exist on LNG-IUS insertion more than a few
hours of birth, and in a location other than the delivery room.
The advantages to immediate postpartum IUD insertion justify further investigation to
accurately define the associated rates of IUD expulsion, and IUD use, at six months
postpartum. For instance, this timing may be well suited for women who did not receive
complete family planning counseling prior to delivery. In busy clinical settings, the clinician
who is most skilled at postpartum insertion may not be available on the labor ward.
Additionally, the infant status is known and the risk of postpartum hemorrhage has
decreased. The primary objective of this study was to determine the feasibility of placing the
LNG-IUS in women after a vaginal birth, and after transfer to the postpartum ward, but
before discharge from the hospital. The secondary objectives were to assess the feasibility of
our study design to inform future studies of immediate postpartum LNG-IUS insertion. We
focused on the LNG-IUS in this feasibility study for two reasons: in our hospital the LNG-
IUS is more popular, and when we embarked upon this study there were no reported data on
postpartum placement of the LNG-IUS beyond the postplacental timeframe.
2. Methods
This was a prospective case-series that took place at the University of North Carolina at
Chapel Hill from July 2009 through October 2010. The Institutional Review Board of the
University of North Carolina at Chapel Hill approved the study. We obtained an FDA IND
(No.104, 220) and registered the study at Clinical Trials.gov (NCT00997932).
All women were recruited from the UNC Women's Hospital Obstetrics prenatal clinics and
were patients of residents and faculty. Women who attended prenatal care at University of
North Carolina's Women Hospital and who intended to use the LNG-IUS after the birth of
their infant were invited to enroll. Eligibility criteria included age 18–40 years and currently
pregnant with a singleton gestation of at least 27 completed weeks estimated gestational age,
and with no known complications of pregnancy including, but not limited to, preeclampsia,
non-gestational diabetes, and anemia. English- and Spanish-speaking women were enrolled.
Additional criteria included anticipated vaginal delivery, no intention to leave the area for 7
months after enrollment, no known uterine anomalies, no known allergies to any
components of the LNG-IUS, no history of cesarean delivery, no treatment of pelvic
inflammatory disease within three months prior to the start of the pregnancy, no medical or
personal conditions that in the judgment of study staff precluded participation in the study,
and no contraindications to use of the LNG-IUS.
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After delivery, participants were interviewed on the postpartum floor and their medical
records were reviewed to confirm none of the following secondary exclusions had occurred
during labor or delivery: endometritis or chorioamnionitis during the intrapartum period;
membranes ruptured for greater than 24 h prior to delivery; fever greater than or equal to
38°C; the need to use additional medications other than oxytocin and/or misoprostol to
control postpartum bleeding. Women who had any of the secondary exclusion criteria
described above, or who declined further participation, left the study at this point. We based
our selection of post-delivery exclusion criteria on the report by Hayes et al. [11] because
that was the first report of LNG-IUS insertion after vaginal delivery based in the U.S.
Women who met the post-delivery criteria were brought to the treatment room on the
postpartum ward for LNG-IUS placement by one of the authors (GSS, AGB or EO) using
the technique described by O'Hanley at al. as a guide [12]. The clinician performed a
bimanual exam and uterine sound to determine uterine size and cervical dilation, and the
angle of the uterus to assess the angle of uterus and the uterine cavity. This information was
used to identify whether placement by hand, inserter or ring forceps would be the best
approach, and for assessment of uterine characteristics associated with expulsion.. We used
either a speculum or we manually parted the vagina to visualize the cervix. The anterior lip
of the cervix was grasped with a ring forcep to provide traction and stability for LNG-IUS
placement. The LNG-IUS was grasped carefully and lightly to avoid crushing the device,
along the stem of the device, at an angle, as described by O'Hanley et al. [12]. The LNG-IUS
was then placed by one of the three investigators. All insertions were done under ultrasound
guidance to confirm fundal placement. The LNG-IUS string was cut to the level of the
vaginal introitus, or just proximal to the introitus.. Discomfort was assessed by asking
women immediately after the LNG-IUS insertion to rate their pain on a scale of 1–10. All
women who received the LNG-IUS received counseling regarding the possible increased
risk of expulsion, and given detailed instructions regarding whom to call in the event of
expulsion. An investigator was available 24 h a day to respond to phone calls.
Follow-up visits were planned at the 4- to 6-week postpartum visit, 3 months and 6 months
after LNG-IUS placement. Data collected at each visit included satisfaction with the LNG-
IUS, whether or not the participants would recommend this method of contraception to a
friend, and a pelvic exam to confirm presence or absence of the LNG-IUS string and an
ultrasound examination to locate the LNG-IUS in the uterus. We also asked questions
regarding participant willingness to be randomized to either timing or IUD type (LNG-IUS
vs. CuT380A) in a future study.
Women who reported expulsion of the LNG-IUS were seen by an investigator and a report
of expulsion was completed. Women received counseling regarding their need for
alternative contraception.
We estimated proportions by LNG-IUS outcomes in the women enrolled, and the women
who received the LNG-IUS using binomial exact calculations. Chi-square for comparison of
proportions, with Fisher's exact test where appropriate, and parametric and non-parametric t-
tests for comparison of means and medians were used to describe differences between
women who did and did not receive the LNG-IUS, and women who did and did not have a
spontaneous expulsion of the LNG-IUS.
3. Results
Forty women enrolled from July 2009 through February 2010. One woman did not deliver at
UNC Women's Hospital. Five women (13%) were not medically eligible to receive the
LNG-IUS due to cesarean delivery (n=4) and preeclampsia (n=1). Three women did not
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receive the LNG-IUS because their births were missed by study staff. One woman changed
her mind and decided against receiving the LNG-IUS when undergoing postpartum
assessment by study staff and one woman had a failed attempted insertion due to uterine
position. Thus, 29 of the original 40 women (73%) received the LNG-IUS prior to discharge
from the hospital.
The baseline characteristics of the women were similar between the women who received
the LNG-IUS and those who did not (Table 1). All 29 women who received the LNG-IUS
reported they would recommend placement at this time frame again, despite 12 (41%)
women having had a laceration (all second degree) at birth.
Eleven of the 29 women [38% (95% CI 21,58)] who received the LNG-IUS had a
spontaneous expulsion. The women who had spontaneous LNG-IUS expulsion were
younger (21 years compared to 26) than the women who did not have an expulsion
(p=0.0082). All other demographic and physical characteristics at the time of LNG-IUS
placement were similar including number of hours between vaginal birth and IUD insertion,
and estimated uterine size and cervical dilation (Table 2). Ten of the expulsions were
complete. The one incomplete expulsion was identified when the woman came in for an
interim study visit due to reported discomfort and the LNG-IUS was visualized protruding
from the cervix. Ten expulsions occurred before the six-week follow-up visit, and one
occurred one week after the six-week follow-up visit. Six of the expulsions occurred within
14 days of LNG-IUS placement.
Two women were lost to follow-up after insertion despite multiple attempts at contact. After
the first follow-up, one woman moved out-of-state and one requested LNG-IUS removal.
One woman was lost to follow-up after the second visit.
Five participants contacted study staff prior to the first follow-up visit requesting to be seen
for string trimming. One woman removed her LNG-IUS herself in this time period because
the strings were painful and irritating.
4. Discussion
Placement of the LNG-IUS after birth but before discharge from the hospital, in a treatment
room on the postpartum floor, was acceptable to women. The expulsion rate of 38% had
statistical instability due to the small sample size of this feasibility study. However, our
report may assist with individual counseling of women interested in postpartum LNG-IUS
placement, and informs future study designs.
The published literature on immediate postpartum LNG-IUS placement, especially more
than 6 h after vaginal birth and after women had left the labor and delivery unit, is limited.
Dahlke et al. [6] randomized 46 women to LNG-IUS placement within 10 min, 10 min to 48
h after, or 6 weeks after vaginal birth. However, 14 of the 15 women randomized to receive
the LNG-IUS 10 min to 48 h later actually received the LNG-IUS within 30 min, and all
women received the LNG-IUS on the labor and delivery unit.
Reported spontaneous expulsions in postpartum LNG-IUS studies have ranged from 10% to
28%. Although our expulsion rate (38%) is higher than previous reports, the lower limit of
the confidence interval, at 21%, falls within previous reports [7,8,11]. The 38% 6-month
expulsion rate we report also falls within the wide range of reported expulsions in previous
studies of CuT380A immediate postpartum placement. One prospective study in Turkey
reported an expulsion rate of 70%, whereas another multicenter report estimated an
expulsion rate of only 5% when the IUDs were placed by experienced clinicians [9,10]. This
wide range of reported expulsion rates underscores the need for additional studies to better
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define the rates of expulsion, and which factors may be associated with success or failure.
Reasons for our high expulsion rate may be that none of the authors had prior experience
with postpartum IUD insertion, however this could be generalized to a clinical setting in
which postpartum IUD insertion is being introduced. An additional important limiting factor
in much of the published literature on postpartum IUD placement has been the lack of
specific information on the time interval between placenta delivery and IUD insertion [3],
the inclusion of the time interval in our data report is strength of our study. One relevant
clinical aspect of our study is that we did not collect data on analgesia use during labor and
delivery or at the time of LNG-IUS insertion. We did not offer analgesia to the women at the
time of LNG-IUS insertion.
In conclusion we found that immediate postpartum placement of the LNG-IUS on a
postpartum ward was feasible and acceptable for the women in our study. Our reported
expulsion rate of 38% should be interpreted with caution, and fully considered in the larger
context of contraceptive continuation and unwanted pregnancy prevention. The focus of this
feasibility study was on the women who received an LNG-IUS, and did not have a
spontaneous expulsion. Therefore, our study is limited because we did not follow women
who had expulsions to measure whether or not they had an IUD reinserted by their primary
care provider. Consequently we did not report the proportion of women using the LNG-IUS
at 6 months. The role of reinsertion after a postpartum expulsion may be important in overall
IUD use. For instance, even when 24–28% of women have an LNG-IUS expulsion, many
will return for a new LNG-IUS placement, such that use of the LNG-IUS at 6 months will
be up to 93% [7]. Finally, our findings can assist clinicians, and investigators, in identifying
an expulsion rate for study design purposes, and for counseling women who may be
interested in postpartum placement of the LNG-IUS.
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Table 1
Baseline characteristics by whether or not women received the IUD in the hospital
Characteristic Received LNG-IUS postpartum in hospital p-value
Yes (n=29) No (n=11)
Age 23 [21, 29] 23 [21, 25] 0.47
Gravidity 3 [1,4] 2 [1,4] 0.64
Parity 1 [0, 2] 0 [0, 1]
EGA at study enrollment 35 [32, 37] 31 [29, 36] 0.19
EGA at start of prenatal care 11 [8, 21] 10 [8, 15] 0.78
Race 0.64
 White 17 (59) 7 (64)
 Black 9(31) 2 (18)
 Other 3(10) 2 (18)
Hispanic ethnicity 7(24) 2 (18) 0.69
Married or cohabitating 9 (31) 3 (27) 0.82
Employed 2 (7) 1 (10) 0.02
Prior use of contraceptive
 Intrauterine contraception 9 (31) 3 (27) 0.82
 Oral contraception 21 (75) 6 (55) 0.36
 Transdermal patch 6 (21) 1 (10) 0.37
 Vaginal ring 1 (4) 0 (0) 0.53
 Depot medroxyprogesterone acetate 11 (40) 5 (45) 0.73
 Condom 23 (82) 8 (72) 0.51
N(%) unless otherwise stated; Median [1st,3rd quartiles]; EGA: Estimated gestational age
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Table 2
Characteristics of the 29 women who received the LNG-IUS, at insertion, by whether or not the LNG-IUS
expelled during the study period
Characteristic Not expelled (N=18) Expelled (n=11) p-value
Age 26 [23, 29] 21 [21, 24] <0.01
Gravidity 3 [2,4] 3 [1,4] 0.61
Parity 2 [1,2] 1 [0,2] 0.34
Married or cohabitating 7 (39) 2(18)
Time interval IUD insertion (h) 19 [11,24] 23 [12,27] 0.43
Cervix dilation (cm) 3 [2,4] 2 [2,4] 0.18
Uterine size at insertion (wks) 18 [16, 18] 19 [18,20] 0.10
Received perineal lacerations at delivery 5 (28) 7(64) 0.06
Reported discomfort, scale 1–10 1 [1,3] 3 [1,6] 0.21
Would recommend to a friend at insertion 18(100) 11(100)
Method of insertion 0.59
 Hand 2 (11) 2 (20)
 Forceps 17 (89) 8 (80)
 Inserter 0 0
IUD in place at study exit
 Yes 17 0
 No 1 11
Data represented as n(%) with 95% confidence interval unless otherwise stated, or median [1st, 3rdquartiles].
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